中文简体
中文简体
English
HOME
ABOUT US
Company Profile
Company Culture
Company Honor
R&D
Technology Platform
Pipelines
NEWS
Press Release
Awards
CAREERS
CONTACT US
中文简体
中文简体
English
Search
Committed to Pioneering Innovation in Drug Development
ABOUT US
Putting Patients First, Innovation for All
Pursuing Excellence, Unwavering Persistence
R&D
Championing Patient Well-being,
Ensuring a Healthy Future
CAREERS
innovation
R&D
Precision Delivery Technology Platform
Beihai Biotech, with a global footprint and ambitious aspirations, has developed a Proprietary Precision Delivery Technology Platform.
Learn More
PDC Technology Platform
Beihai Biotech has developed a cutting-edge platform of Peptide-Drug Conjugate (PDC).
Learn More
A Robust Pipeline of 8 Promising Innovative Drug Candidates
Diverse Therapeutic Areas: Breast cancer, non-small cell lung cancer, prostate cancer, stomach cancer...
Learn More
Technology Platform
Pipelines
NEWS
NEWS
Beihai Biotech announced that its innovative cancer drug, BH009 (marketed as BEIZRAY), has received approval from the U.S. Food and Drug Administration (FDA)
Learn More
U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY™)
Learn More
Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School
Learn More
Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates
Learn More
See More
米兰.体育 (中国) 官方网站
|
乐竞体育·(LEJING SPORTS)官方网站
|
开云登陆入口
|
乐鱼网页版-乐鱼(中国)
|
华球体育_华球(中国)公司
|
开云真人（中国）体育官方网站
|
星空体育·（StarSky Sports）官方网站
|
米兰手机版app
|
乐动
|
